Antibody Testing Market Size, Share, Growth, Analysis & Trends

According to The Insight Partners – The global antibody testing market has established itself as a critical segment within the life sciences and diagnostics industry. According to a detailed research report published by The Insight Partners, the market was valued at US$ 7.26 billion in 2021 and is projected to reach US$ 11.58 billion by 2028, registering a compound annual growth rate (CAGR) of 6.9% during the forecast period from 2021 to 2028. This robust growth trajectory is underpinned by a convergence of public health imperatives, technological advancements, and expanding clinical applications across diverse disease areas.

Get Sample PDF @ https://www.theinsightpartners.com/sample/TIPAR00016492 

Understanding Antibody Testing

Antibody testing, also referred to as serological testing, involves screening blood samples for the presence of immunoglobulins — Y-shaped proteins produced by the immune system in response to infections, vaccinations, or autoimmune activity. These tests play a dual role: they serve as diagnostic tools for identifying current or past exposure to pathogens, and as clinical indicators for autoimmune conditions such as those triggered by antinuclear antibodies (ANA). ANA tests detect antibodies that mistakenly target the body's own healthy cells, causing tissue inflammation, joint pain, and fatigue. The breadth of antibody testing applications — spanning COVID-19 detection, cardiovascular disease management, oncology, and endocrine disorders — makes this an increasingly indispensable component of modern diagnostics.

Key Market Drivers

The primary growth engine for the antibody testing market has been the global response to the COVID-19 pandemic. As SARS-CoV-2 spread rapidly after being declared a public health emergency in January 2020, real-time PCR and antibody tests became foundational tools for managing the outbreak. Antibody detection kits proved invaluable in determining whether individuals had developed immunity following infection or vaccination, supporting both clinical decision-making and return-to-work strategies globally. Regulatory bodies including the U.S. FDA, NIH, CDC, and BARDA collaborated to make performance data for antibody test kits publicly accessible, driving accelerated adoption.

Beyond the pandemic, the rising global prevalence of chronic and infectious diseases, a rapidly aging population, and growing government support for diagnostic programs have collectively fueled demand. The long-term opportunity in plasma therapy for critically ill COVID-19 patients — and the emergency use authorizations granted to new antibody testing products — further bolstered market confidence.

Antibody Testing Market Segmentation Insights

The antibody testing market is segmented by product, indication, end user, and geography. By product, kits dominated the market in 2021, accounting for 54.08% of total market share, driven by wide manufacturer participation from companies such as Abbott, F. Hoffmann-La Roche, and Bio-Rad Laboratories. Among kit types, serological test kits held the highest share. On the indication front, infectious diseases captured the largest share at 26.44% in 2021 and are also expected to register the highest CAGR through 2028. Among end users, diagnostic laboratories led with a 41.58% share in 2021, a position expected to strengthen through the forecast period.

Regional Landscape

Geographically, North America leads the market, supported by strong healthcare infrastructure, regulatory clarity, and significant investment in diagnostics innovation. Asia Pacific is emerging as a high-growth region, with China, India, and Japan contributing substantially due to rising healthcare expenditure and expanding diagnostic capabilities.

Get Full Copy of This Report @ https://www.theinsightpartners.com/buy/TIPAR00016492 

Competitive Landscape & Recent Developments

The market features key players including Thermo Fisher Scientific, Abbott Laboratories, Bio-Rad Laboratories, Beckton Dickinson, F. Hoffmann-La Roche, Agilent Technologies, DiaSorin, Zeus Scientific, Abcam, and Trinity Biotech. In February 2021, Agilent launched the Dako SARS-CoV-2 IgG ELISA kit for qualitative IgG antibody detection, while Abbott had introduced a serology test for SARS-CoV-2 IgG in April 2020 using ARCHITECT instruments capable of processing up to 200 tests per hour.

Future Outlook

Looking ahead, the antibody testing market is poised for sustained expansion beyond 2028. The emergency use authorizations fast-tracked during the pandemic have accelerated development pipelines, and many of these innovations are expected to transition into permanent diagnostic standards. As infectious disease threats evolve and healthcare systems invest in pandemic preparedness, demand for rapid serological testing will remain strong.

The growing use of antibody testing in oncology and endocrine disease management represents a significant untapped frontier. Advances in multiplex testing platforms — enabling simultaneous detection of multiple antibodies — and the integration of artificial intelligence in result interpretation are set to transform throughput and clinical precision. Biopharmaceutical companies are also expected to increase reliance on antibody testing for drug development and therapeutic monitoring, further broadening the market's commercial scope. With governments continuing to invest in diagnostic infrastructure and chronic disease surveillance, the antibody testing market is well-positioned for long-term, innovation-driven growth across both developed and emerging economies.

Related Reports @

Antibiotic-Stewardship-Biomarkers-Market Size and Share 2028

Viral-Antigens-Market Revenue and Demand Analysis: Growth Forecast till 2028

Haematology-Cell-Counters-Market Overview, Growth, Trends

About Us -

The Insight Partners provides comprehensive syndicated and tailored market research services in the healthcare, technology, and industrial domains. Renowned for delivering strategic intelligence and practical insights, the firm empowers businesses to remain competitive in ever-evolving global markets.

Contact Us:

Contact Person: Ankit Mathur

E-mail: ankit.mathur@theinsightpartners.com

Phone: +1-646-491-9876